# Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis

> **NCT07571525** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 40 (estimated)

## Conditions studied

- Myasthenia Gravis (MG)
- Myasthenia Gravis Associated With Thymoma
- Thymoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07571525
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2029-09-14
- **Final completion:** 2029-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07571525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07571525, "Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07571525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*